![Ole Wiborg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Ole Wiborg first degree
Entity | Entity type | Industry | |
---|---|---|---|
Extinct | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ole Wiborg via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TopoTarget UK Ltd.
![]() TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member | |
Allarity Therapeutics Europe ApS
![]() Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Operating Officer | |
AELIS FARMA | Biotechnology | Chairman | |
Gerselconsult ApS | Chief Executive Officer | ||
AcceptFinans ApS
![]() AcceptFinans ApS Finance/Rental/LeasingFinance Part of GE Aerospace, AcceptFinans ApS is a Danish company that provides consumer lending services. The company is located in Denmark. AcceptFinans was acquired by General Electric Capital Corp. from Gjensidige Nor Sparebanken ASA on August 03, 2001. | Finance/Rental/Leasing | President | |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Chief Operating Officer | |
Bond 2 Development 2 Gp Ltd. | Director/Board Member | ||
Oncology Venture US, Inc.
![]() Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Buhl Krone Holding ApS | Chief Executive Officer | ||
WNTRESEARCH AB | Pharmaceuticals: Other | Corporate Officer/Principal | |
Liplasome Pharma ApS
![]() Liplasome Pharma ApS Pharmaceuticals: MajorHealth Technology Liplasome Pharma ApS operates as a biotech company focusing on oncology. It develops drug delivery technologies for anticancer market. The firm's drug delivery platform consists of a lipid based drug delivery system for the intravenous transportation of anticancer drugs and prodrugs. The company was founded in 2002 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CESSATECH A/S | Pharmaceuticals: Major | Chairman | |
CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Chief Operating Officer | |
Bond Avillion 2 Development LP | Director/Board Member | ||
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Chr. Hansen A/S
![]() Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
European Society for Medical Oncology
![]() European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
International Association for the Study of Lung Cancer | Corporate Officer/Principal | ||
Danish Society of Medical Oncology | Corporate Officer/Principal | ||
Danish Society of Internal Medicine | Corporate Officer/Principal | ||
ALK-ABELLÓ A/S | Biotechnology | Director/Board Member | |
Bavarian Nordic GmbH
![]() Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree | |
Copenhagen Business School | College/University | Undergraduate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fonden Lundbeck International Neuroscience Foundation | Investment Trusts/Mutual Funds | Chairman | |
Lundbeck Cognitive Therapeutics A/S | Director/Board Member | ||
GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
University of Southern Denmark | College/University | Undergraduate Degree |
Statistics
International
Denmark | 22 |
United Kingdom | 6 |
United States | 5 |
Sweden | 4 |
France | 2 |
Sectoral
Health Technology | 18 |
Commercial Services | 4 |
Consumer Services | 4 |
Health Services | 3 |
Retail Trade | 2 |
Operational
Director/Board Member | 18 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 5 |
Chief Operating Officer | 5 |
Chairman | 4 |
Most connected contacts
Insiders | |
---|---|
Anders Gersel Pedersen | 24 |
Ulla Hald Buhl | 12 |
Leif Schimmel Hamø | 3 |
- Stock Market
- Insiders
- Ole Wiborg
- Company connections